The change of soluble programmed cell death ligand-1 (sPD-L1): A new predictor of prognosis in hypopharyngeal squamous cell carcinoma patients treated with radiotherapy.

Cancer Biomark · 2025 · PMC12288420 · PMID 40420575

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

did not reach statistical significanceP = 0.053so close (0.05 < p ≤ 0.1)

T4 stage patients showed trends towards a higher plasma sPD-L1 level at diagnosis compared to T1-3 stage patients, but the difference did not reach statistical significance [41.664 (27.817, 68.093) pg/ml vs. 55.691 (46.032, 90.601) pg/ml, P = 0.053; Figure 3B ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.